Immunotherapy News and Research

Latest Immunotherapy News and Research

Patients with biliary tract cancer have altered genetic architecture in immune system

Patients with biliary tract cancer have altered genetic architecture in some immune system receptors.

26 Jun 2019

New findings could expand use of immunotherapy to fight cancers

More types of cancer could potentially be destroyed by patients’ own immune cells, thanks to new research by Cardiff University.

26 Jun 2019

Researchers explore new immune checkpoint for head and neck cancer

A checkpoint may delay travelers but it can help give cancer free rein by suppressing the natural immune response that should destroy it, researchers say.

25 Jun 2019

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.

24 Jun 2019

Elite group of immune cells plays key role in fighting tumors

Immunotherapies hold promise as a way to prompt a patient's own immune system to fight cancer cells. Yet immunotherapies only work in about 30 percent of patients-;and they can cause dangerous side effects.

24 Jun 2019

Study reveals genetic signature of failed immune response to cancer

Our immune system is programmed to destroy cancer cells. Sometimes it has trouble slowing disease progression because it doesn't act quickly or strongly enough.

21 Jun 2019

Researchers highlight need for ethnic and ancestral diversity in large-scale genomic studies

A new multicenter analysis led by researchers at the Fred Hutchinson Cancer Research Center, the Icahn School of Medicine at Mount Sinai and other institutions found the inclusion of diverse, multiethnic populations in large-scale genomic studies is critical for reducing health disparities and accurately representing genetics-related disease risks in all populations.

20 Jun 2019

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development, it was announced today (Tuesday).

19 Jun 2019

Researchers discover redundancies in immune cells

Researchers at ETH Zurich have discovered redundancies in the biochemical signaling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.

18 Jun 2019

Duke researchers identify enzyme involved in regulating growth, spread of breast cancers

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing.

18 Jun 2019

Researchers find way to reinvigorate exhausted immune cells and stop cancer

The human immune system relies on a delicate balance of finely tuned cell types that keep germs and cancerous cells in check.

18 Jun 2019

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.

13 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

Immune checkpoint inhibitors are an emerging type of cancer immunotherapy that uses the immune system to attack cancer cells.

12 Jun 2019

The immune system in women may be different from men finds study

Research has shown that women have a different immune system from men and may respond differently to different immune disease processes.

11 Jun 2019

Novel agent shown to have dual mechanism of action to eliminate cancer

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.

11 Jun 2019

Complex molecular conversation is key to the establishment of 'hot tumor'

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

11 Jun 2019

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet's Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

10 Jun 2019

Researchers propose a new look at the role of ferroptosis in cancer development

Professor of Ghent University and Lead Researcher at the Institute of Biology and Biomedicine of the Lobachevsky University Dmitri Krysko together with scientists from Germany, Professor Marcus Conrad and Professor Jose Pedro Friedmann Angeli recently published an article in the journal Nature Reviews Cancer, one of the highest-rated journals that occupies the 2nd line in the oncology section among 223 journals in this category and has an impact factor of 42.78 according to WoS data.

7 Jun 2019

Three-drug combination could be effective therapy for people with advanced melanoma

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

7 Jun 2019

Immunotherapy News and Research

Latest Immunotherapy News and Research

Patients with biliary tract cancer have altered genetic architecture in immune system

New findings could expand use of immunotherapy to fight cancers

Researchers explore new immune checkpoint for head and neck cancer

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Elite group of immune cells plays key role in fighting tumors

Study reveals genetic signature of failed immune response to cancer

Researchers highlight need for ethnic and ancestral diversity in large-scale genomic studies

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Researchers discover redundancies in immune cells

Duke researchers identify enzyme involved in regulating growth, spread of breast cancers

Researchers find way to reinvigorate exhausted immune cells and stop cancer

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

Scientists identify potential target for Parkinson's treatment

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

The immune system in women may be different from men finds study

Novel agent shown to have dual mechanism of action to eliminate cancer

Complex molecular conversation is key to the establishment of 'hot tumor'

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

Researchers propose a new look at the role of ferroptosis in cancer development

Three-drug combination could be effective therapy for people with advanced melanoma

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in